stella
beta
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer — Stella
Recruiting
Back to Head and Neck Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
The University of Chicago, Chicago, Illinois
View full record on ClinicalTrials.gov